Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CALL
Invesco Solar ETF
TAN
$1.37B
| $457K | ﹤0.01% |
+9,300
| New | +$448K |
|
3852
FVCBankcorp
FVCB
$337M
| $455K | ﹤0.01% |
32,710
+1,891
| +6% | +$24.2K |
|
3853
Primis Financial Corp
FRST
$411M
| $454K | ﹤0.01% |
32,660
+1,331
| +4% | +$15.1K |
|
|
BHR
3854
Braemar Hotels & Resorts
BHR
$139M
| $453K | ﹤0.01% |
157,773
+33,792
| +27% | +$91.1K |
|
3855
Ranpak Holdings
PACK
$464M
| $452K | ﹤0.01% |
83,624
+8,244
| +11% | +$43.3K |
|
3856
Weibo
WB
$1.91B
| $452K | ﹤0.01% |
44,213
-50,244
| -53% | -$539K |
|
3857
Banco Macro
BMA
$5.1B
| $451K | ﹤0.01% |
5,006
-12,719
| -72% | -$961K |
|
3858
CAMP4 Therapeutics
CAMP
$284M
| $451K | ﹤0.01% |
73,601
+73,531
| +105,044% | +$313K |
|
3859
Blue Ridge Bankshares
BRBS
$339M
| $450K | ﹤0.01% |
105,462
+10,371
| +11% | +$45K |
|
|
SLI
3860
Standard Lithium
SLI
$594M
| $450K | ﹤0.01% |
100,710
| – | – |
|
3861
Corsair Gaming
CRSR
$1.4B
| $450K | ﹤0.01% |
75,699
+6,956
| +10% | +$48.4K |
|
3862
NVE Corp
NVEC
$591M
| $448K | ﹤0.01% |
7,545
+619
| +9% | +$41.4K |
|
3863
Latham Group
SWIM
$921M
| $445K | ﹤0.01% |
70,046
+6,241
| +10% | +$43.7K |
|
3864
Toyota
TM
$223B
| $445K | ﹤0.01% |
2,077
-5,913
| -74% | -$1.2M |
|
3865
Barnes & Noble Education
BNED
$417M
| $444K | ﹤0.01% |
48,293
+25,593
| +113% | +$226K |
|
|
KWY
3866
Kingsway Corp
KWY
$279M
| $443K | ﹤0.01% |
32,931
+2,728
| +9% | +$37.4K |
|
|
SVC
3867
Service Properties Trust
SVC
$1.1B
| $443K | ﹤0.01% |
48,127
+4,558
| +10% | +$45.8K |
|
3868
Galectin Therapeutics
GALT
$317M
| $443K | ﹤0.01% |
+106,401
| New | +$560K |
|
3869
KVH Industries
KVHI
$142M
| $443K | ﹤0.01% |
63,487
-1,188
| -2% | -$7.17K |
|
3870
CALL
Yeti Holdings
YETI
$3.85B
| $442K | ﹤0.01% |
10,000
| – | – |
|
3871
Claros Mortgage Trust
CMTG
$262M
| $440K | ﹤0.01% |
143,901
+13,886
| +11% | +$45.3K |
|
3872
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $440K | ﹤0.01% |
6,782
-21,393
| -76% | -$1.32M |
|
|
SEVN
3873
Seven Hills Realty Trust
SEVN
$174M
| $440K | ﹤0.01% |
49,399
+22,587
| +84% | +$212K |
|
3874
Princeton Bancorp
BPRN
$295M
| $439K | ﹤0.01% |
12,647
+2,961
| +31% | +$97.4K |
|
3875
Aldeyra Therapeutics
ALDX
$91.7M
| $438K | ﹤0.01% |
84,471
+7,827
| +10% | +$40.2K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.